GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Pilulka Lekarny AS (XPRA:PINK) » Definitions » EV-to-EBITDA

Pilulka Lekarny AS (XPRA:PINK) EV-to-EBITDA : -4.73 (As of Jun. 21, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Pilulka Lekarny AS EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Pilulka Lekarny AS's enterprise value is Kč432 Mil. Pilulka Lekarny AS's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was Kč-91 Mil. Therefore, Pilulka Lekarny AS's EV-to-EBITDA for today is -4.73.

The historical rank and industry rank for Pilulka Lekarny AS's EV-to-EBITDA or its related term are showing as below:

XPRA:PINK' s EV-to-EBITDA Range Over the Past 10 Years
Min: -3929.59   Med: -927.19   Max: -4.23
Current: -4.72

During the past 6 years, the highest EV-to-EBITDA of Pilulka Lekarny AS was -4.23. The lowest was -3929.59. And the median was -927.19.

XPRA:PINK's EV-to-EBITDA is ranked worse than
100% of 466 companies
in the Healthcare Providers & Services industry
Industry Median: 12.69 vs XPRA:PINK: -4.72

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-21), Pilulka Lekarny AS's stock price is Kč135.00. Pilulka Lekarny AS's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was Kč-64.626. Therefore, Pilulka Lekarny AS's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Pilulka Lekarny AS EV-to-EBITDA Historical Data

The historical data trend for Pilulka Lekarny AS's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pilulka Lekarny AS EV-to-EBITDA Chart

Pilulka Lekarny AS Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
Get a 7-Day Free Trial - -381.79 -3,716.90 -201.96 -7.99

Pilulka Lekarny AS Semi-Annual Data
Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA Get a 7-Day Free Trial - -381.79 -3,716.90 -201.96 -7.99

Competitive Comparison of Pilulka Lekarny AS's EV-to-EBITDA

For the Pharmaceutical Retailers subindustry, Pilulka Lekarny AS's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pilulka Lekarny AS's EV-to-EBITDA Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Pilulka Lekarny AS's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Pilulka Lekarny AS's EV-to-EBITDA falls into.



Pilulka Lekarny AS EV-to-EBITDA Calculation

Pilulka Lekarny AS's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=431.601/-91.303
=-4.73

Pilulka Lekarny AS's current Enterprise Value is Kč432 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Pilulka Lekarny AS's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was Kč-91 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pilulka Lekarny AS  (XPRA:PINK) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Pilulka Lekarny AS's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=135.00/-64.626
=At Loss

Pilulka Lekarny AS's share price for today is Kč135.00.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Pilulka Lekarny AS's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was Kč-64.626.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Pilulka Lekarny AS EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Pilulka Lekarny AS's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Pilulka Lekarny AS (XPRA:PINK) Business Description

Traded in Other Exchanges
N/A
Address
Drahobejlova 1073/36, Prague, CZE, 190 00
Pilulka Lekarny AS operates an online pharmaceutical store by distribution of medicinal products. The store offers over-the-counter-drugs, dietary supplements, baby foods, mother care products, cosmetics, other prescription drugs, sport nutritional products, diagnostic test kits, orthopaedic supplies, first aid kits, and other related products.

Pilulka Lekarny AS (XPRA:PINK) Headlines

From GuruFocus

LEE DANNER & BASS INC Buys 3, Sells 2 in 3rd Quarter

By GuruFocus Research GuruFocus Editor 10-31-2022

Top 5 4th Quarter Trades of LEE DANNER & BASS INC

By GuruFocus Research GuruFocus Editor 02-02-2023